LATEST NEWS

SCOTUS Should Reverse FDA Approval of Dangerous Abortion Drug Mifepristone

Project 21 Commentary /
This week the U.S. Supreme Court will hear oral arguments in a case that is key to the safety of women and children. Over two decades ago, the U.S. Food and Drug Administration (FDA) approved the use of a dangerous abortion drug, mifepristone, and since its approval, both the Obama ...
SIGN UP FOR EXCLUSIVE UPDATES
Sign up for National Center for Public Policy Research’s monthly newsletter, event invitations, or program-specific updates.

Publications

Latest News

Follow Us

Our Work In Video

Media Appearances

Social Media

The National Center for Public Policy Research is a communications and research foundation supportive of a strong national defense and dedicated to providing free market solutions to today’s public policy problems. We believe that the principles of a free market, individual liberty and personal responsibility provide the greatest hope for meeting the challenges facing America in the 21st century.